The relationship of age, race, and ethnicity with survival in dialysis patients.

PubWeight™: 1.32‹?› | Rank: Top 10%

🔗 View Article (PMC 3675850)

Published in Clin J Am Soc Nephrol on March 28, 2013

Authors

Guofen Yan1, Keith C Norris, Alison J Yu, Jennie Z Ma, Tom Greene, Wei Yu, Alfred K Cheung

Author Affiliations

1: Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, Virginia 22908-0717, USA. guofen.yan@virginia.edu

Articles citing this

Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis. Am J Nephrol (2015) 1.46

Impact of age, race and ethnicity on dialysis patient survival and kidney transplantation disparities. Am J Nephrol (2014) 1.06

Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States. Clin J Am Soc Nephrol (2013) 1.05

Race/ethnicity, age, and risk of hospital admission and length of stay during the first year of maintenance hemodialysis. Clin J Am Soc Nephrol (2014) 0.99

Why minorities live longer on dialysis: an in-depth examination of the Danish nephrology registry. Nephrol Dial Transplant (2016) 0.84

Racial differences in survival among hemodialysis patients after coronary artery bypass grafting. Int J Environ Res Public Health (2013) 0.82

Interstate Variation in Receipt of Nephrologist Care in US Patients Approaching ESRD: Race, Age, and State Characteristics. Clin J Am Soc Nephrol (2015) 0.82

Racial-ethnic disparities in mortality and kidney transplant outcomes among pediatric dialysis patients. Pediatr Nephrol (2016) 0.79

Racial and Ethnic Disparities in Survival of Children with ESRD. J Am Soc Nephrol (2016) 0.79

Asymmetric dimethylarginine, race, and mortality in hemodialysis patients. Clin J Am Soc Nephrol (2014) 0.78

Racial and Ethnic Disparities in Use of and Outcomes with Home Dialysis in the United States. J Am Soc Nephrol (2015) 0.78

Relationship Between Age and Timely Placement of Vascular Access In Incident Patients on Hemodialysis. Nephrol Nurs J (2015) 0.77

Survival on dialysis among American Indians and Alaska Natives with diabetes in the United States, 1995-2010. Am J Public Health (2014) 0.77

Social Determinants of Racial Disparities in CKD. J Am Soc Nephrol (2016) 0.76

Racial and Ethnic Disparities in Graft and Recipient Survival in Elderly Kidney Transplant Recipients. J Am Geriatr Soc (2015) 0.75

Younger black patients have a higher risk of infection mortality that is mostly non-dialysis related: A national study of cause-specific mortality among U.S. maintenance dialysis patients. Hemodial Int (2016) 0.75

Hemodialysis Disparities in African Americans: The Deeply Integrated Concept of Race in the Social Fabric of Our Society. Semin Dial (2017) 0.75

Lesson Learned in Mortality and Kidney Transplant Outcomes among Pediatric Dialysis Patients. J Am Soc Nephrol (2017) 0.75

High Serum Alkaline Phosphatase, Hypercalcaemia, Race, and Mortality in South African Maintenance Haemodialysis Patients. Int J Nephrol (2017) 0.75

Relationship Between Age and Pre-End Stage Renal Disease Care in Elderly Patients Treated with Maintenance Hemodialysis. Nephrol Nurs J (2016) 0.75

Association between medical insurance type and survival in patients undergoing peritoneal dialysis. BMC Nephrol (2015) 0.75

Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies. Am J Kidney Dis (2016) 0.75

The Survival of Roma Minority Patients on Chronic Hemodialysis Therapy - A Romanian Multicenter Survey. PLoS One (2016) 0.75

Age, Race and Cardiovascular Outcomes in African American Veterans. Ethn Dis (2016) 0.75

Racial and Ethnic Differences in Mortality Associated with Serum Potassium in a Large Hemodialysis Cohort. Am J Nephrol (2017) 0.75

Articles cited by this

Contribution of major diseases to disparities in mortality. N Engl J Med (2002) 8.72

Eight Americas: investigating mortality disparities across races, counties, and race-counties in the United States. PLoS Med (2006) 8.70

Association of race and age with survival among patients undergoing dialysis. JAMA (2011) 5.82

Environmental health disparities: a framework integrating psychosocial and environmental concepts. Environ Health Perspect (2004) 4.28

Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol (2008) 2.96

Unraveling the racial disparities associated with kidney disease. Kidney Int (2005) 2.72

Revisiting survival differences by race and ethnicity among hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study. J Am Soc Nephrol (2006) 2.65

Racial differences in mortality among those with CKD. J Am Soc Nephrol (2008) 2.53

Race, gender, and socioeconomic disparities in CKD in the United States. J Am Soc Nephrol (2008) 2.43

Dose of hemodialysis and survival: differences by race and sex. JAMA (1998) 2.08

Racial and survival paradoxes in chronic kidney disease. Nat Clin Pract Nephrol (2007) 2.06

To have and have not: Health and health care disparities in chronic kidney disease. Kidney Int (2003) 1.90

Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients. J Bone Miner Res (2010) 1.79

Let's get serious about racial and ethnic disparities. J Am Soc Nephrol (2008) 1.79

Role of nutritional status and inflammation in higher survival of African American and Hispanic hemodialysis patients. Am J Kidney Dis (2011) 1.74

Racial and ethnic disparities in end-stage kidney failure-survival paradoxes in African-Americans. Semin Dial (2007) 1.66

Survival advantage for adult Hispanic hemodialysis patients? Findings from the end-stage renal disease clinical performance measures project. J Am Soc Nephrol (2003) 1.58

Survival analysis of patients undergoing dialysis. JAMA (1987) 1.53

Racial ethnic differences in rates and determinants of deceased donor kidney transplantation. J Am Soc Nephrol (2011) 1.48

Survival disparities within American and Israeli dialysis populations: learning from similarities and distinctions across race and ethnicity. Semin Dial (2010) 1.18

Inflammation and the paradox of racial differences in dialysis survival. J Am Soc Nephrol (2011) 1.17

Racial and gender differences in arteriovenous fistula use among incident hemodialysis patients. Am J Nephrol (2010) 1.04

Racial survival paradox of dialysis patients: robust and resilient. Am J Kidney Dis (2012) 1.03

Is the malnutrition-inflammation complex the secret behind greater survival of African-American dialysis patients? J Am Soc Nephrol (2011) 0.96

Hispanic ethnicity and vascular access use in patients initiating hemodialysis in the United States. Clin J Am Soc Nephrol (2011) 0.96

Associations of race and ethnicity with anemia management among patients initiating renal replacement therapy. J Natl Med Assoc (2007) 0.94

The role of race in survival among patients undergoing dialysis. Nephrol News Issues (2011) 0.91

Race, age, and mortality among patients undergoing dialysis. JAMA (2011) 0.84

Articles by these authors

A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81

Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27

A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med (2015) 19.14

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis (2003) 15.00

Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99

Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA (2002) 12.29

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med (2006) 10.97

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science (2009) 10.78

In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73

Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect (2005) 10.66

Regulation of cellular metabolism by protein lysine acetylation. Science (2010) 10.55

Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52

Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93

Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48

Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA (2008) 7.50

Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis (2002) 7.03

A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell (2006) 6.15

Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00

Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90

PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42. Cell (2007) 5.84

Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell (2010) 5.73

The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med (2005) 5.45

Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol (2004) 5.29

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25

Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer. J Clin Oncol (2013) 5.21

A navigator for human genome epidemiology. Nat Genet (2008) 5.07

Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis (2007) 5.06

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet (2003) 4.79

A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet (2007) 4.46

A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction (2003) 4.37

The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27

Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet (2010) 3.91

Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis (2010) 3.87

Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial. Am J Kidney Dis (2011) 3.81

Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71

Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med (2009) 3.69

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol (2011) 3.52

Development and validation of a CGH microarray for clinical cytogenetic diagnosis. Genet Med (2005) 3.39

Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis (2008) 3.34

Phase I study of trastuzumab-DM1, an HER2 antibody-drug conjugate, given every 3 weeks to patients with HER2-positive metastatic breast cancer. J Clin Oncol (2010) 3.06

Uric acid and long-term outcomes in CKD. Am J Kidney Dis (2009) 2.86

Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. Am J Kidney Dis (2010) 2.83

Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. Hum Mol Genet (2005) 2.80

Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med (2013) 2.74

Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP). Arch Intern Med (2012) 2.74

Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol (2006) 2.74

Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med (2007) 2.71

Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein. Proc Natl Acad Sci U S A (2004) 2.66

Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol Cell (2012) 2.54

Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease. J Am Soc Nephrol (2006) 2.54

Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int (2009) 2.52

Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science (2013) 2.49

Related causal frameworks for surrogate outcomes. Biometrics (2009) 2.46

Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis (2012) 2.42

High urine volume and low urine osmolality are risk factors for faster progression of renal disease. Am J Kidney Dis (2003) 2.41

Phosphatidylinositol-3,4,5-trisphosphate regulates the formation of the basolateral plasma membrane in epithelial cells. Nat Cell Biol (2006) 2.39

The rationale and design of the AASK cohort study. J Am Soc Nephrol (2003) 2.34

Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. Am J Epidemiol (2006) 2.34

Epithelial polarity and tubulogenesis in vitro. Trends Cell Biol (2003) 2.31

Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Mol Cell (2011) 2.29

Building an academic-community partnered network for clinical services research: the Community Health Improvement Collaborative (CHIC). Ethn Dis (2006) 2.25

Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension (2008) 2.24

Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol (2003) 2.21

The association between BP and mortality in patients on chronic peritoneal dialysis. Nephrol Dial Transplant (2005) 2.21

Single- and multilocus allelic variants within the GABA(B) receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence. Am J Hum Genet (2005) 2.18

Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2010) 2.18

Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int (2004) 2.16

Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol (2009) 2.15

Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med (2007) 2.14

C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int (2005) 2.13

Cell-polarity dynamics controls the mechanism of lumen formation in epithelial morphogenesis. Curr Biol (2008) 2.13

Effect of frequent hemodialysis on residual kidney function. Kidney Int (2013) 2.10

Health insurance status and hypertension monitoring and control in the United States. Am J Hypertens (2007) 2.09

Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol (2005) 2.07

Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment. Ann Pharmacother (2013) 1.99

Daily hemodialysis: a systematic review. Clin J Am Soc Nephrol (2005) 1.97

Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol (2013) 1.96

Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int (2002) 1.93

Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis. J Am Soc Nephrol (2010) 1.92

Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation (2002) 1.91

Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol (2012) 1.90

Outcomes associated with microalbuminuria: effect modification by chronic kidney disease. J Am Coll Cardiol (2013) 1.89

Preoperative statin administration is associated with lower mortality and decreased need for postoperative hemodialysis in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth (2009) 1.88

Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2011) 1.88

Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney Int (2010) 1.88

The associations between race and geographic area and quality-of-care indicators in patients approaching ESRD. Clin J Am Soc Nephrol (2013) 1.87

High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int (2011) 1.86

Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation (2012) 1.86